Aldesleukin Completed Phase 1 / 2 Trials for Breast Cancer / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00027807Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT00019136Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer